Literature DB >> 20133949

Impaired cardiovascular function in primary biliary cirrhosis.

David E J Jones1, Kieren Hollingsworth, Gulnar Fattakhova, Guy MacGowan, Roy Taylor, Andrew Blamire, Julia L Newton.   

Abstract

Cardiovascular system dysregulation in the form of autonomic dysfunction is common at all stages of the disease process in the autoimmune liver disease primary biliary cirrhosis (PBC) and associates with the symptom of fatigue. The mechanisms underpinning autonomic dysfunction in PBC are, however, at present unclear. In this study we set out to explore, for the first time, cardiac structure and function in PBC using impedance cardiography (ICG) and magnetic resonance methodologies. ICG was assessed beat to beat in response to orthostasis (by head-up tilt) in age and sex case-matched high-fatigue and low-fatigue PBC groups (assessed by Fatigue Impact Scale), normal control subjects (n = 15 each group) and a liver disease control cohort (primary sclerosing cholangitis). Cardiac structure and bioenergetics were examined in 15 of the PBC subjects and 8 of the normal control subjects by magnetic resonance spectroscopy and cine imaging. Capacity of the left ventricle to respond to orthostasis [left ventricular ejection time (LVET)] was impaired in PBC compared with matched normal control subjects (P = 0.05). This was a PBC-specific phenomenon unrelated to fatigue status. PBC patients exhibited significantly lower cardiac muscle phosphocreatine-to-ATP ratio (PCr/ATP ratio; measure of cardiac bioenergetic integrity) compared with control subjects (P < 0.01). PCr/ATP <1.6 (indicative of increased risk of death in cardiomyopathy) was present in 6/15 (40%) PBC patients (0/8 control subjects; P < 0.05). Cardiac structure and function were similar in all measures of left ventricular morphology between control subjects and PBC. The close relationship between PCr/ATP and LVET seen in normal subjects (r(2) = 0.6; P < 0.05) was lost in PBC patients, a finding compatible with myocardial dysfunction. Significant correlation was seen between fatigue severity in PBC and fall in cardiac output on orthostasis (r(2) = 0.25; P = 0.005). Our findings suggest the presence of altered myocardial function in PBC. Autonomic "dysfunction" may, rather than being an abnormal process, represent a compensatory mechanism to increase cardiac return to mitigate these effects.

Entities:  

Mesh:

Year:  2010        PMID: 20133949      PMCID: PMC2867424          DOI: 10.1152/ajpgi.00501.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  31 in total

1.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

2.  Autonomic and peripheral neuropathy in primary biliary cirrhosis: evidence of small sensory fibre damage and prolongation of the QT interval.

Authors:  P Kempler; A Váradi; E Kádar; F Szalay
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

3.  Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use.

Authors:  M I Prince; O F James; N P Holland; D E Jones
Journal:  J Hepatol       Date:  2000-03       Impact factor: 25.083

4.  Impedance cardiography as a noninvasive technique for atrioventricular interval optimization in cardiac resynchronization therapy.

Authors:  Martin U Braun; Andreas Schnabel; Thomas Rauwolf; Matthias Schulze; Ruth H Strasser
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

5.  Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis.

Authors:  Julia L Newton; John Allen; Simon Kerr; David E J Jones
Journal:  Liver Int       Date:  2006-03       Impact factor: 5.828

6.  Comparison of cine magnetic resonance imaging and Doppler echocardiography for evaluation of left ventricular diastolic function.

Authors:  A M Kudelka; D A Turner; P R Liebson; J E Macioch; J Z Wang; J T Barron
Journal:  Am J Cardiol       Date:  1997-08-01       Impact factor: 2.778

7.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

Authors:  S Neubauer; M Horn; M Cramer; K Harre; J B Newell; W Peters; T Pabst; G Ertl; D Hahn; J S Ingwall; K Kochsiek
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

8.  Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome.

Authors:  Arnold Peckerman; John J LaManca; Kristina A Dahl; Rahul Chemitiganti; Bushra Qureishi; Benjamin H Natelson
Journal:  Am J Med Sci       Date:  2003-08       Impact factor: 2.378

9.  Cardiovascular complications of cirrhosis.

Authors:  S Møller; J H Henriksen
Journal:  Postgrad Med J       Date:  2009-01       Impact factor: 2.401

10.  Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.

Authors:  Michaela Scheuermann-Freestone; Per L Madsen; David Manners; Andrew M Blamire; Robin E Buckingham; Peter Styles; George K Radda; Stefan Neubauer; Kieran Clarke
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

View more
  23 in total

Review 1.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

2.  Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure.

Authors:  W-F Ng; A J Stangroom; A Davidson; K Wilton; S Mitchell; J L Newton
Journal:  QJM       Date:  2012-09-13

3.  Unveiling a hidden 31 P signal coresonating with extracellular inorganic phosphate by outer-volume-suppression and localized 31 P MRS in the human brain at 7T.

Authors:  Jimin Ren; Ty Shang; A Dean Sherry; Craig R Malloy
Journal:  Magn Reson Med       Date:  2018-02-09       Impact factor: 4.668

4.  Risk of incident coronary artery disease in patients with primary biliary cirrhosis.

Authors:  Chunya Wang; Pan Zhao; Weiwei Liu
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 5.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

6.  Reduced thoracic fluid content in early-stage primary biliary cirrhosis that associates with impaired cardiac inotropy.

Authors:  Pawel Zalewski; David Jones; Ieuan Lewis; James Frith; Julia L Newton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-18       Impact factor: 4.052

Review 7.  Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy.

Authors:  Martin I Wah-Suarez; Christopher J Danford; Vilas R Patwardhan; Z Gordon Jiang; Alan Bonder
Journal:  Frontline Gastroenterol       Date:  2019-01-09

8.  Left ventricular torsion, energetics, and diastolic function in normal human aging.

Authors:  Kieren G Hollingsworth; Andrew M Blamire; Bernard D Keavney; Guy A Macgowan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-16       Impact factor: 4.733

9.  Exercise Training Attenuates Cirrhotic Cardiomyopathy.

Authors:  Sérgio Luiz Borges de Souza; Gustavo Augusto Ferreira Mota; Cristina Schmitt Gregolin; Milena do Nascimento; Renata Azevedo Melo Luvizotto; Silmeia Garcia Zanati Bazan; Mário Mateus Sugizaki; Luis Fernando Barbisan; Antonio Carlos Cicogna; André Ferreira do Nascimento
Journal:  J Cardiovasc Transl Res       Date:  2020-04-03       Impact factor: 4.132

10.  The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort.

Authors:  Greta Pells; George F Mells; Marco Carbone; Julia L Newton; Andrew J Bathgate; Andrew K Burroughs; Michael A Heneghan; James M Neuberger; Darren B Day; Samantha J Ducker; Richard N Sandford; Graeme J Alexander; David E J Jones
Journal:  J Hepatol       Date:  2013-03-04       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.